These results indicated that Siglec-5 promoted M2 polarization of tumor-associated macrophages (TAMs) and inhibited M1 polarization by enhancing SHP2 activity while suppressing SYK phosphorylation under hypoxic conditions. Here, SYK is linked to neoplasm.